49th JSTCT Annual Meeting (JSTCT2027) Japanese Society for Transplantation and Cellular Therapy [Kanagawa Prefecture]
JSTCT2027, the 49th Annual Meeting of the Japanese Society for Transplantation and Cellular Therapy, will take place on March 4–6, 2027, at PACIFICO Yokohama North in Yokohama, Japan. The meeting brings together research in hematopoietic cell transplantation, immune cell therapy, hematologic disorders, transplant complications and patient care. Its theme is “Genesis of the Future – Embracing Life, Weaving the Future.” The meeting is planned as an in-person event, with selected content available on demand after the conference.
JSTCT2027 Theme
Genesis of the Future – Embracing Life, Weaving the Future
The President’s welcome message emphasizes carrying forward the experience of earlier transplant specialists and developing new approaches with younger researchers. It highlights the potential of immunotherapy and genomic medicine to complement transplantation, with the aim of improving future treatment strategies. Read the official Welcome Message.
JSTCT2027 General Information
- Conference name: 49th JSTCT Annual Meeting (JSTCT2027) Japanese Society for Transplantation and Cellular Therapy
- Dates: March 4 (Thu.) – March 6 (Sat.), 2027
- Format: In-person meeting with selected on-demand content
- Venue: PACIFICO Yokohama North
- Address: 1-1-2 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan
- On-demand period: March 23–May 10, 2027 (scheduled)
- Society: Japanese Society for Transplantation and Cellular Therapy (JSTCT)
- Organizer: Jikei University
Conference Organization
- President: Shingo Yano, Professor and Chairperson, Department of Internal Medicine, Division of Clinical Oncology/Hematology, Jikei University
- Meeting office: Division of Clinical Oncology/Hematology, Jikei University
- Congress Secretariat: c/o JTB Communication Design, Inc.
- Address: Celestine Shiba Mitsui Bldg., 3-23-1 Shiba, Minato-ku, Tokyo 105-8335, Japan
- Contact: jstct2027@jtbcom.co.jp
Call for Abstracts
- Submission period: July 1–September 7, 2026 (closed; extended from August 31)
- Presentation formats: Oral and poster presentations, selected through peer review
- Eligibility: First authors generally must be JSTCT members; exceptions apply to residents, undergraduate students (with certification), and authors affiliated with institutions outside Japan.
- English submission guidelines: Title: up to 100 characters including spaces. Abstract: up to 1,800 characters including spaces. Presentations, abstracts and presentation materials should be prepared in English under the English submission guidelines.
- Notification: Abstract decisions and presentation schedules are expected by email in mid-November 2026.
The general submission period has ended. Consult the English Call for Abstracts for abstract preparation, eligibility, ethics approval and conflict-of-interest requirements. The Japanese call also describes workshop submissions and selection of high-scoring oral abstracts for plenary consideration.
Research Areas and Workshop Topics
The following areas summarize the official abstract categories and workshop call. They are not a confirmed list of scheduled lectures.
- Stem cell biology, histocompatibility, stem cell collection, graft sources and conditioning regimens.
- Transplant immunity, immune reconstitution, graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects.
- Immunotherapy, cellular therapy and gene therapy in preclinical and clinical research.
- Transplant outcomes in leukemia, myelodysplastic syndromes, lymphoma and multiple myeloma; residual disease and relapse.
- Infectious complications, early and late transplant complications, follow-up and quality of life.
- Nursing, rehabilitation, nutrition, infection control, transplant coordination, multidisciplinary care and AI-based analysis.
Four topics in the workshop call
- New approaches to hematologic malignancies using bispecific antibodies.
- Advances in GVHD treatment and practical management.
- Donor and graft-source selection in the era of post-transplant cyclophosphamide (PTCy).
- Post-transplant treatment strategies for hematologic malignancies with a high risk of relapse.
Workshop topics are translated from the Japanese Call for Abstracts (Japanese).
Special Abstracts, Special Session and JSTCT2027 Award
- Special abstract submissions: Invited presenters should submit online by their individually notified deadline. Special abstract submission (Japanese)
- Special discussion session: The organizer invited practical questions from transplant care teams, including graft selection, immunosuppression, nursing and long-term follow-up. Topic proposals closed July 31, 2026. The planned discussion is in Japanese. Special session information (Japanese)
- JSTCT2027 Award: The award supports first authors who are young physicians or medical students under 36, or medical staff under 40, as of March 5, 2027. Up to 100 recipients are planned, with JPY 30,000–50,000 in support per recipient. Applications are closed; results are expected in late November 2026. Award details (Japanese)
Program and Registration
As of November 13, 2026, the detailed scientific program, registration instructions and registration fees have not yet been published. Online registration is scheduled to open on December 1, 2026.
Important for international participants: The official English registration page lists May 6, 2027 as the online registration deadline (Japan Standard Time, UTC+9). The Japanese page lists the following provisional registration periods, with a later closing date. These dates differ; please follow the English registration instructions and confirm the applicable deadline with the Congress Secretariat before registering.
| Category | Published dates |
|---|---|
| Early registration (Japanese site) | December 1, 2026 – January 25, 2027 (scheduled) |
| Late registration (Japanese site) | February 1 – May 10, 2027 (scheduled) |
| On-demand viewing | March 23 – May 10, 2027 (scheduled) |
Official updates: Program / Registration (English) / Registration schedule (Japanese) / Information for Participants / Information for Presenters.
Industry Sponsorship and Exhibition
The meeting invites support from companies and organizations through sponsorship and donations. The deadlines for co-sponsored seminars and symposia (August 25, 2026) and equipment and book exhibits (October 30, 2026) have passed. Program/abstract book and name badge advertising applications are listed through November 30, 2026; app, intersession and website banner advertising through January 20, 2027. Consult the official sponsorship and donation information (Japanese) for current availability and requirements.
Venue Access
- Minatomirai Line: From Minatomirai Station, use Exit 2 (Icho-dori) and follow the route toward Keiyu Hospital to reach the North building.
- JR / Yokohama Municipal Subway: Sakuragicho Station is approximately a 12-minute walk from the convention complex; allow extra time for the North building.
- From Yokohama Station: The BAYSIDE BLUE articulated bus serves the PACIFICO Yokohama North stop.
The North building is located at 1-1-2 Minato Mirai, as confirmed by the Japanese conference overview and venue information. Some conference banners and the English Access page list the main complex address (1-1-1); use the North building address for navigation. See PACIFICO Yokohama official English access guide and conference access information.
Official Websites
• General Information
• Welcome Message
• Program
• Call for Abstracts
• Registration (English)
• Information for Presenters
• Information for Participants
• Access
• Special Abstract Submission (Japanese)
• Special Session (Japanese)
• JSTCT2027 Award (Japanese)
• Sponsorship and Donations (Japanese)
• Registration Schedule (Japanese)
• JSTCT Official Website (English)
• JSTCT Annual Meetings (English)
• PACIFICO Yokohama Access (English)
Information checked: November 13, 2026. Dates, program details and registration arrangements may change. Please consult the official conference website for the latest information.


